New funding awards - March 2012

By ajz6@dhe.duke.edu
Department of Medicine faculty have received notice of the following research, clinical trials, CME or other training awards. [tabs style="vertical"] [tab title="Sponsored research"]Nelson J. Chao of Cell Therapy has received a sub-award (ONR-N00014-12-1-0142-) through the National Marrow Donor Program for a project entitled "RITN Agreement." Total funding will be $8,000. Hayden B. Bosworth of General Internal Medicine has received a sub-award (5P50-HL105184-02) through the University of North Carolina for a project entitled "Heart Healthy Senior Project." Total funding will be $39,865. Thomas L. Ortel of Hematology has received an award (1U50-DD000897-01) from the Centers for Disease Control and Prevention for a project entitled "Population-based Surveillance And Outcomes of Venous Thromboembolism." Total funding will be $600,000. John A. Bartlett of Infectious Diseases has received a sub-award (UM1-AI068636-06) through Social & Scientific Systems, Inc. for a project entitled "ACTG A5280 Additional Funds BRS-ACURE-S-12-000056-002288." Total funding will be $250. Wendy A. Prudhomme-O'Meara of Infectious Diseases has received an award (1R21-AI095979-01A1) from the National Institutes of Health for a project entitled "Sustainable Financial Incentives To Improve Prescription Practices For Malaria." Total funding will be $320,720. Jason E. Stout of Infectious Diseases has received a sub-award (5-U52PS416676) through the NC Department of Health and Human Services for a project entitled "Epidemiology/General Communicable Disease Control." Total funding will be $96,679. Jason E. Stout of Infectious Diseases has received a sub-award (10FED1007388-VA-FHI) through Family Health International for a project entitled "Tuberculosis Trial Consortium." Total funding will be $129,544. Michael A. Hauser of Medical Genetics has received a sub-award (1R43-HG005796-01A1) through Advanced Liquid Logic for a project entitled "Microfluidic DNA Quality Control Solution for Biobanks." Total funding will be $25,161. Erik H. Knelson (Mentor: Gerard C. Blobe) of Medical Oncology has received an award (1 F30-CA168043-01) from the National Institutes of Health for a project entitled "The Role of Stroma-derived Soluble TbetaRIII in Neuroblastoma." Total funding will be $47,232. Tereza Martinu of Pulmonary, Allergy & Critical Care Medicine has received an award from the Parker B. Francis Foundation for a project entitled "Role of dendritic cells in pulmonary graft-versus-host disease." Total funding will be $156,000. Timothy J. McMahonof Pulmonary, Allergy & Critical Care Medicine has received an award (1R21-HL113943-01) from the National Institutes of Health for a project entitled "Impaired release of antiadhesive ATP from stored RBCs: a novel transfusion lesion." Total funding will be $235,800.[/tab] [tab title="Industry-sponsored clinical trials"]John K. Harrison of Cardiology has received an award from Medtronic, Inc. for a project entitled "CoreValve Continued Access Study (Extreme Risk Patients)." Total funding will be $1,535,228. Manesh R. Patel of Cardiology has received an award from Medtronic, Inc. for a project entitled "Resistant Hypertension Project." Total funding will be $10,000. Andrew Wang of Cardiology has received an award from Gilead Sciences, Inc. for a project entitled "Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery: Pilot, Screening Study." Total funding will be $534,995. Keith M. Sullivan of Cell Therapy has received an award from Millennium Pharmaceuticals, Inc. for a project entitled "11th Annual Fellows Research Retreat." Total funding will be $25,000. Mark N. Feinglos of Endocrinology has received an award from Prodigy Diabetes Care, LLC for a project entitled "Blood Glucose System Accuracy Study." Total funding will be $40,111. Andrew J. Muir of Gastroenterology has received an award from F. Hoffmann-La Roche Ltd for a project entitled "Non-Interventional, Prospective, Cohort Study of the Effectiveness, Safety, and Utilization of 2 Pegylated Interferon-Based Direct Acting Antiviral Triple Therapies in the Mgt of Genotype 1 Chronic Hepatitis C in Routine Clinical Practice in the USA." Total funding will be $77,711. Andrew J. Muir of Gastroenterology has received an award from Vertex Pharmaceuticals Inc. for a project entitled "Vertex Study Number: VX11-222-106." Total funding will be $37,312. Andrew J. Muir of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "Gilead Project." Total funding will be $3,082,701. Aatif Husain of Neurology has received an award from Upsher-Smith Laboratories, Inc. for a project entitled "An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects with Seizure Clusters." Total funding will be $61,068. Burton L. Scott of Neurology has received an award from Merz Pharmaceuticals for a project entitled "CD Flex: Open Label Study of Xeomin in Subjects with cervical Dystonia." Total funding will be $100,590. Jeffrey Peppercorn of Medical Oncology has received an award from Bristol-Myers Squibb for a project entitled "CA191-011 BMS-754807." Total funding will be $150,490. Richard F. Riedel of Medical Oncology has received an award from Eisai, Inc. for a project entitled "A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin with Dacarbazine in Subjects with Soft Tissue Sarcoma.." Total funding will be $596,632. Marvaretta M. Stevensonof Medical Oncology has received an award from Pfizer, Inc. for a project entitled "A randomized double blind phase 3 efficacy and safety study of pf-00299804 versus erlotinib for the treatment of advance non-small cell lung cancer following progression after, or intolerance to, at least one prior chemotherapy." Total funding will be $226,110. John S. Sundy of Pulmonary, Allergy & Critical Care Medicine has received an award from Bristol-Myers Squibb for a project entitled "Duke/BMS Collaboration - Preclinical Biomarker Study." Total funding will be $155,000. Julia KL Walker of Pulmonary, Allergy & Critical Care Medicine has received an award from Aerie Pharmaceuticals, Inc. for a project entitled "ROCK effect on OVA phenotype." Total funding will be $110,390. Virginia B. Kraus of Rheumatology has received an award from Bioiberica, S.A. for a project entitled "Study of the Effects of Chondroitin Sulphate on Uric acid Solubility and Subsequent Inflammasome Activation." Total funding will be $102,428. [/tab] [/tabs]

Share